Polydex Pharmaceuticals Limited (OTC Pink: POLXF) (the “Company” or “Polydex”) announced today that it has entered into a Plan of Arrangement agreement (the “Arrangement Agreement”) whereby BioSpectra, Inc. and BioSpectra Canada, Ltd (together, “BioSpectra”) will acquire all of the outstanding common and preferred shares of the Company for total consideration of $6,940,000. Polydex, based in Toronto, Ontario, is engaged in the manufacturing of bulk pharmaceutical intermediates for the worldwide veterinary pharmaceutical industry and also the development, manufacturing and marketing of biotechnology-based products for the human pharmaceutical market.
Read the full article: Polydex Pharmaceuticals Limited and BioSpectra Inc. Announce Business Combination //
Source: https://www.globenewswire.com/news-release/2023/04/27/2656830/8154/en/Polydex-Pharmaceuticals-Limited-and-BioSpectra-Inc-Announce-Business-Combination.html